Skip to main content
. 2009 Jan 14;47(3):560–565. doi: 10.1128/JCM.01756-08

TABLE 2.

Age-specific prevalence rates of MuV antibodies in the healthy control group

Age group (yr) No. of individuals Vaccination status % Positive for MuV IgG Avg MuV IgG TV
0-4 13 Vaccinated 92.3 1.9
5-9 19 Vaccinated 68.4 1.4
10-15 16 Vaccinated 43.8 1.0
>15 3 Nonvaccinated 100.0 2.7